Project Grant R43FD006301

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $306,872 to Xcellassay, Inc. to validate a novel bioassay platform for detecting anabolic androgenic steroid (AAS) doping in youth athletics. The proposed research aims to develop a high-throughput blood-based screening method that can reliably identify individuals using testosterone and testosterone-like substances, which are Schedule III...

This National Science Foundation (NSF) Cooperative Agreement award for $998,064 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a new testing standard and benchmarking platform to measure the biological effects of functional ingredients used in dietary supplements, foods, beverages, and skincare products. The project, led by Canomiks, Inc., will use genomics and artificial intelligence technologies to create high-throughput, cost-effective...

This Project Grant award from the National Institute of Justice (CFDA 16.560) in the amount of $251,505 provided funding to Western Illinois University to develop advanced analytical methods for the quantification and stability analysis of psychotropic cannabinoids derived from hemp. The key products to be delivered under this two-year project include: Optimized LC-DAD-ESI/MS/MS methods capable of baseline separation and quantification of up to 20 cannabinoid compounds, including isomers,...

This U18FD008346 Cooperative Agreement award from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) provides $138,784 to Washington State University (WSU) to develop and validate an HPLC-FLD (high-performance liquid chromatography with fluorescence detection) quantification method for measuring thiamine (vitamin B1) levels in animal feeds, tissues, and blood samples. The project aims to establish a standardized analytical procedure that can be implemented by all...

The National Institute of Justice (NIJ) awarded a $726,360 Project Grant to Virginia Commonwealth University (VCU) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP), CFDA 16.838. The funding will support VCU's efforts to address analytical challenges with proliferating commercially available THC analogues. Key project activities include monitoring e-liquids to identify emerging THC analogs, developing and validating analytical methods for product and biological...

The National Institute of Justice awarded a $392,196 Project Grant under the Forensics Training and Technical Assistance Program (CFDA 16.044) to RTI International. The goal of this 24-month project is to develop a software platform for automating and improving the reliability of colorimetric drug testing, which is a commonly used but limited technique in forensic science. Phase 1 will involve generating test images and defining optimal analysis parameters, while Phase 2 will incorporate machine...

This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...

This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), funded under the Alcohol Research Programs (CFDA 93.273), provides $399,293 to Echelon Biosciences Inc. to develop a prototype rapid point-of-care phosphatidylethanol (PEth) competitive lateral flow immunoassay. PEth is considered the most reliable long-term biomarker for detecting alcohol consumption, but current testing methods are costly and have slow turnaround times. The goal of this Phase I...

This $489,500 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to evaluate remote procedures for assessing cannabis use and non-use in young adults aged 18-30 through oral fluid testing. The study will assess the feasibility of video-recorded and live-observed daily oral fluid delta-9-THC testing to determine its accuracy in identifying cannabis use and non-use intervals, compared to self-reported data. The...

This Project Grant award from the National Institute of Justice (NIJ) under the NIJ Research, Evaluation, and Development Project Grants program (CFDA 16.560) will develop and validate analytical methods for differentiating hemp and marijuana using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and liquid chromatography-photodiode array-mass spectrometry (LC-PDA-MS). The $216,763 award, spanning January 1, 2025 to December 31, 2026, will enable researchers at Sam Houston State...